Global Solid Preparation Drug Industry Research & Trends Analysis Report
According to A Latest intelligence report published by Market IntelliX, the global market for Solid Preparation Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Solid Preparation Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Solid Preparation Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Tablet segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Solid Preparation Drug include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report aims to provide a comprehensive study of the global market for Solid Preparation Drug. Report Highlights:
(1) Global Solid Preparation Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Solid Preparation Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Solid Preparation Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Solid Preparation Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Solid Preparation Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Solid Preparation Drug, capacity, production and trends.
(7) Solid Preparation Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Tablet
Capsules
Other
Market segment by application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Teva
Boehringer Ingelheim
Biogen
Astellas
1 Market Overview
1.1 Solid Preparation Drug Definition
1.2 Global Solid Preparation Drug Market Size and Forecast
1.2.1 By Revenue, Global Solid Preparation Drug Market Size, 2018-2029
1.2.2 By Sales Volume, Global Solid Preparation Drug Market Size, 2018-2029
1.2.3 Global Solid Preparation Drug Price Trend, 2018-2029
1.3 China Solid Preparation Drug Market Size and Forecast
1.3.1 By Revenue, China Solid Preparation Drug Market Size, 2018-2029
1.3.2 By Sales Volume, China Solid Preparation Drug Market Size, 2018-2029
1.3.3 China Solid Preparation Drug Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Solid Preparation Drug Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Solid Preparation Drug Share in Global Market, 2018-2029
1.4.3 Solid Preparation Drug Market Size: China VS Global, 2018-2029
1.5 Solid Preparation Drug Market Dynamics
1.5.1 Solid Preparation Drug Market Drivers
1.5.2 Solid Preparation Drug Market Restraints
1.5.3 Solid Preparation Drug Industry Trends
1.5.4 Solid Preparation Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Solid Preparation Drug Revenue by Company, 2018-2023
2.2 Global Solid Preparation Drug Sales Volume by Company, 2018-2023
2.3 Global Solid Preparation Drug Price by Company, 2018-2023
2.4 Global Solid Preparation Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Solid Preparation Drug Concentration Ratio
2.6 Global Solid Preparation Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Solid Preparation Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Solid Preparation Drug Revenue by Company, 2018-2023
3.2 China Solid Preparation Drug Sales Volume by Company, 2018-2023
3.3 China Solid Preparation Drug Solid Preparation Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Solid Preparation Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Solid Preparation Drug Domestic VS Export
3.6 China Market, Solid Preparation Drug Import & Export
3.6.1 China Market, Solid Preparation Drug Import & Export, 2018-2029
3.6.2 China Solid Preparation Drug Import & Export Trends
3.6.3 Main Sources of China Solid Preparation Drug Import
3.6.4 Export Destination of China Solid Preparation Drug
4 Solid Preparation Drug Production by Region
4.1 Global Solid Preparation Drug Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Solid Preparation Drug Manufacturers
4.3 Global Major Manufacturers, Solid Preparation Drug Capacity Expansion and Future Plans
4.4 Global Solid Preparation Drug Capacity by Region
4.5 Global Solid Preparation Drug Production by Region
4.5.1 Global Solid Preparation Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Solid Preparation Drug Production by Region, 2018-2023
4.5.3 Global Solid Preparation Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Solid Preparation Drug Industry Chain
5.2 Solid Preparation Drug Upstream Analysis
5.2.1 Solid Preparation Drug Core Raw Materials
5.2.2 Main Manufacturers of Solid Preparation Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Solid Preparation Drug Production Mode
5.6 Solid Preparation Drug Procurement Model
5.7 Solid Preparation Drug Industry Sales Model and Sales Channels
5.7.1 Solid Preparation Drug Sales Model
5.7.2 Solid Preparation Drug Typical Distributors
6 Sights by Type
6.1 Solid Preparation Drug Classification
6.1.1 Tablet
6.1.2 Capsules
6.1.3 Other
6.2 By Type, Global Solid Preparation Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Solid Preparation Drug Revenue, 2018-2029
6.4 By Type, Global Solid Preparation Drug Sales Volume, 2018-2029
6.5 By Type, Global Solid Preparation Drug Price, 2018-2029
7 Sights by Application
7.1 Solid Preparation Drug Segment by Application
7.1.1 Hospital
7.1.2 Retail Pharmacy
7.1.3 Other
7.2 By Application, Global Solid Preparation Drug Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Solid Preparation Drug Revenue, 2018-2029
7.4 By Application, Global Solid Preparation Drug Sales Volume, 2018-2029
7.5 By Application, Global Solid Preparation Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Solid Preparation Drug Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Solid Preparation Drug Revenue, 2018-2029
8.3 By Region, Global Solid Preparation Drug Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Solid Preparation Drug Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Solid Preparation Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Solid Preparation Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Solid Preparation Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Solid Preparation Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Solid Preparation Drug Market Size Market Share
8.7 South America
8.7.1 South America Solid Preparation Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Solid Preparation Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Solid Preparation Drug Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Solid Preparation Drug Revenue, 2018-2029
9.3 By Country, Global Solid Preparation Drug Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Solid Preparation Drug Market Size, 2018-2029
9.4.2 By Company, U.S. Solid Preparation Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Solid Preparation Drug Market Size, 2018-2029
9.5.2 By Company, Europe Solid Preparation Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Solid Preparation Drug Market Size, 2018-2029
9.6.2 By Company, China Solid Preparation Drug Sales Volume Market Share, 2022
9.6.3 By Type, China Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Solid Preparation Drug Market Size, 2018-2029
9.7.2 By Company, Japan Solid Preparation Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Solid Preparation Drug Market Size, 2018-2029
9.8.2 By Company, South Korea Solid Preparation Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Solid Preparation Drug Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Solid Preparation Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Solid Preparation Drug Market Size, 2018-2029
9.10.2 By Company, India Solid Preparation Drug Sales Volume Market Share, 2022
9.10.3 By Type, India Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Solid Preparation Drug Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Solid Preparation Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Solid Preparation Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Solid Preparation Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.1.2 Johnson & Johnson Solid Preparation Drug Models, Specifications and Application
10.1.3 Johnson & Johnson Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Johnson & Johnson Company Profile and Main Business
10.1.5 Johnson & Johnson Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.2.2 Novartis Solid Preparation Drug Models, Specifications and Application
10.2.3 Novartis Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 Roche
10.3.1 Roche Company Information, Head Office, Market Area and Industry Position
10.3.2 Roche Solid Preparation Drug Models, Specifications and Application
10.3.3 Roche Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Roche Company Profile and Main Business
10.3.5 Roche Recent Developments
10.4 AbbVie
10.4.1 AbbVie Company Information, Head Office, Market Area and Industry Position
10.4.2 AbbVie Solid Preparation Drug Models, Specifications and Application
10.4.3 AbbVie Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AbbVie Company Profile and Main Business
10.4.5 AbbVie Recent Developments
10.5 Merck & Co.
10.5.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
10.5.2 Merck & Co. Solid Preparation Drug Models, Specifications and Application
10.5.3 Merck & Co. Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Merck & Co. Company Profile and Main Business
10.5.5 Merck & Co. Recent Developments
10.6 Bristol Myers Squibb
10.6.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
10.6.2 Bristol Myers Squibb Solid Preparation Drug Models, Specifications and Application
10.6.3 Bristol Myers Squibb Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Bristol Myers Squibb Company Profile and Main Business
10.6.5 Bristol Myers Squibb Recent Developments
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
10.7.2 GlaxoSmithKline Solid Preparation Drug Models, Specifications and Application
10.7.3 GlaxoSmithKline Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 GlaxoSmithKline Company Profile and Main Business
10.7.5 GlaxoSmithKline Recent Developments
10.8 Pfizer
10.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.8.2 Pfizer Solid Preparation Drug Models, Specifications and Application
10.8.3 Pfizer Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Pfizer Company Profile and Main Business
10.8.5 Pfizer Recent Developments
10.9 Sanofi
10.9.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.9.2 Sanofi Solid Preparation Drug Models, Specifications and Application
10.9.3 Sanofi Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Sanofi Company Profile and Main Business
10.9.5 Sanofi Recent Developments
10.10 Takeda
10.10.1 Takeda Company Information, Head Office, Market Area and Industry Position
10.10.2 Takeda Solid Preparation Drug Models, Specifications and Application
10.10.3 Takeda Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Takeda Company Profile and Main Business
10.10.5 Takeda Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.11.2 AstraZeneca Solid Preparation Drug Models, Specifications and Application
10.11.3 AstraZeneca Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 AstraZeneca Company Profile and Main Business
10.11.5 AstraZeneca Recent Developments
10.12 Bayer
10.12.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.12.2 Bayer Solid Preparation Drug Models, Specifications and Application
10.12.3 Bayer Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Bayer Company Profile and Main Business
10.12.5 Bayer Recent Developments
10.13 Eli Lilly & Co.
10.13.1 Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position
10.13.2 Eli Lilly & Co. Solid Preparation Drug Models, Specifications and Application
10.13.3 Eli Lilly & Co. Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Eli Lilly & Co. Company Profile and Main Business
10.13.5 Eli Lilly & Co. Recent Developments
10.14 Gilead Sciences
10.14.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position
10.14.2 Gilead Sciences Solid Preparation Drug Models, Specifications and Application
10.14.3 Gilead Sciences Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Gilead Sciences Company Profile and Main Business
10.14.5 Gilead Sciences Recent Developments
10.15 Amgen
10.15.1 Amgen Company Information, Head Office, Market Area and Industry Position
10.15.2 Amgen Solid Preparation Drug Models, Specifications and Application
10.15.3 Amgen Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Amgen Company Profile and Main Business
10.15.5 Amgen Recent Developments
10.16 Teva
10.16.1 Teva Company Information, Head Office, Market Area and Industry Position
10.16.2 Teva Solid Preparation Drug Models, Specifications and Application
10.16.3 Teva Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Teva Company Profile and Main Business
10.16.5 Teva Recent Developments
10.17 Boehringer Ingelheim
10.17.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
10.17.2 Boehringer Ingelheim Solid Preparation Drug Models, Specifications and Application
10.17.3 Boehringer Ingelheim Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Boehringer Ingelheim Company Profile and Main Business
10.17.5 Boehringer Ingelheim Recent Developments
10.18 Biogen
10.18.1 Biogen Company Information, Head Office, Market Area and Industry Position
10.18.2 Biogen Solid Preparation Drug Models, Specifications and Application
10.18.3 Biogen Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Biogen Company Profile and Main Business
10.18.5 Biogen Recent Developments
10.19 Astellas
10.19.1 Astellas Company Information, Head Office, Market Area and Industry Position
10.19.2 Astellas Solid Preparation Drug Models, Specifications and Application
10.19.3 Astellas Solid Preparation Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Astellas Company Profile and Main Business
10.19.5 Astellas Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Solid Preparation Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Solid Preparation Drug Market Restraints
Table 3. Solid Preparation Drug Market Trends
Table 4. Solid Preparation Drug Industry Policy
Table 5. Global Solid Preparation Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global Solid Preparation Drug Revenue Market Share by Company, 2018-2023
Table 7. Global Solid Preparation Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Solid Preparation Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global Solid Preparation Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Solid Preparation Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Solid Preparation Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Solid Preparation Drug Manufacturers Product Type
Table 13. China Solid Preparation Drug Revenue by Company, 2018-2023, US$ million
Table 14. China Solid Preparation Drug Revenue Market Share by Company, 2018-2023
Table 15. China Solid Preparation Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Solid Preparation Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Solid Preparation Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Solid Preparation Drug Import & Export Trends
Table 19. Main Sources of China Solid Preparation Drug Import
Table 20. Export Destination of China Solid Preparation Drug
Table 21. Global Headquarters and Manufacturing Base of Solid Preparation Drug Manufacturers
Table 22. Global Major Manufacturers, Solid Preparation Drug Capacity Expansion and Future Plans
Table 23. Global Solid Preparation Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Solid Preparation Drug Production by Region, 2018-2023, (K Units)
Table 25. Global Solid Preparation Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Solid Preparation Drug Upstream (Raw Materials)
Table 27. Global Solid Preparation Drug Typical Customers
Table 28. Solid Preparation Drug Typical Distributors
Table 29. By Type, Global Solid Preparation Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Solid Preparation Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Solid Preparation Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Solid Preparation Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Solid Preparation Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Solid Preparation Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Solid Preparation Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Solid Preparation Drug Sales Volume Market Share, 2018-2029
Table 39. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 40. Johnson & Johnson Solid Preparation Drug Models, Specifications and Application
Table 41. Johnson & Johnson Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Johnson & Johnson Company Profile and Main Business
Table 43. Johnson & Johnson Recent Developments
Table 44. Novartis Company Information, Head Office, Market Area and Industry Position
Table 45. Novartis Solid Preparation Drug Models, Specifications and Application
Table 46. Novartis Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Novartis Company Profile and Main Business
Table 48. Novartis Recent Developments
Table 49. Roche Company Information, Head Office, Market Area and Industry Position
Table 50. Roche Solid Preparation Drug Models, Specifications and Application
Table 51. Roche Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Roche Company Profile and Main Business
Table 53. Roche Recent Developments
Table 54. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 55. AbbVie Solid Preparation Drug Models, Specifications and Application
Table 56. AbbVie Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AbbVie Company Profile and Main Business
Table 58. AbbVie Recent Developments
Table 59. Merck & Co. Company Information, Head Office, Market Area and Industry Position
Table 60. Merck & Co. Solid Preparation Drug Models, Specifications and Application
Table 61. Merck & Co. Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Merck & Co. Company Profile and Main Business
Table 63. Merck & Co. Recent Developments
Table 64. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 65. Bristol Myers Squibb Solid Preparation Drug Models, Specifications and Application
Table 66. Bristol Myers Squibb Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bristol Myers Squibb Company Profile and Main Business
Table 68. Bristol Myers Squibb Recent Developments
Table 69. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
Table 70. GlaxoSmithKline Solid Preparation Drug Models, Specifications and Application
Table 71. GlaxoSmithKline Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. GlaxoSmithKline Company Profile and Main Business
Table 73. GlaxoSmithKline Recent Developments
Table 74. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 75. Pfizer Solid Preparation Drug Models, Specifications and Application
Table 76. Pfizer Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Pfizer Company Profile and Main Business
Table 78. Pfizer Recent Developments
Table 79. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 80. Sanofi Solid Preparation Drug Models, Specifications and Application
Table 81. Sanofi Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Sanofi Company Profile and Main Business
Table 83. Sanofi Recent Developments
Table 84. Takeda Company Information, Head Office, Market Area and Industry Position
Table 85. Takeda Solid Preparation Drug Models, Specifications and Application
Table 86. Takeda Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Takeda Company Profile and Main Business
Table 88. Takeda Recent Developments
Table 89. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 90. AstraZeneca Solid Preparation Drug Models, Specifications and Application
Table 91. AstraZeneca Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. AstraZeneca Company Profile and Main Business
Table 93. AstraZeneca Recent Developments
Table 94. Bayer Company Information, Head Office, Market Area and Industry Position
Table 95. Bayer Solid Preparation Drug Models, Specifications and Application
Table 96. Bayer Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Bayer Company Profile and Main Business
Table 98. Bayer Recent Developments
Table 99. Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position
Table 100. Eli Lilly & Co. Solid Preparation Drug Models, Specifications and Application
Table 101. Eli Lilly & Co. Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Eli Lilly & Co. Company Profile and Main Business
Table 103. Eli Lilly & Co. Recent Developments
Table 104. Gilead Sciences Company Information, Head Office, Market Area and Industry Position
Table 105. Gilead Sciences Solid Preparation Drug Models, Specifications and Application
Table 106. Gilead Sciences Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Gilead Sciences Company Profile and Main Business
Table 108. Gilead Sciences Recent Developments
Table 109. Amgen Company Information, Head Office, Market Area and Industry Position
Table 110. Amgen Solid Preparation Drug Models, Specifications and Application
Table 111. Amgen Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Amgen Company Profile and Main Business
Table 113. Amgen Recent Developments
Table 114. Teva Company Information, Head Office, Market Area and Industry Position
Table 115. Teva Solid Preparation Drug Models, Specifications and Application
Table 116. Teva Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Teva Company Profile and Main Business
Table 118. Teva Recent Developments
Table 119. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 120. Boehringer Ingelheim Solid Preparation Drug Models, Specifications and Application
Table 121. Boehringer Ingelheim Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Boehringer Ingelheim Company Profile and Main Business
Table 123. Boehringer Ingelheim Recent Developments
Table 124. Biogen Company Information, Head Office, Market Area and Industry Position
Table 125. Biogen Solid Preparation Drug Models, Specifications and Application
Table 126. Biogen Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Biogen Company Profile and Main Business
Table 128. Biogen Recent Developments
Table 129. Astellas Company Information, Head Office, Market Area and Industry Position
Table 130. Astellas Solid Preparation Drug Models, Specifications and Application
Table 131. Astellas Solid Preparation Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Astellas Company Profile and Main Business
Table 133. Astellas Recent Developments
List of Figure
Figure 1. Solid Preparation Drug Picture
Figure 2. By Revenue, Global Solid Preparation Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Solid Preparation Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Solid Preparation Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Solid Preparation Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Solid Preparation Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Solid Preparation Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Solid Preparation Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Solid Preparation Drug Share of Global Market, 2018-2029
Figure 10. Global Solid Preparation Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Solid Preparation Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Solid Preparation Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Solid Preparation Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Solid Preparation Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Solid Preparation Drug Domestic VS Export, 2022
Figure 16. Global Solid Preparation Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Solid Preparation Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Solid Preparation Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. Solid Preparation Drug Industry Chain
Figure 20. Solid Preparation Drug Procurement Model
Figure 21. Solid Preparation Drug Sales Model
Figure 22. Solid Preparation Drug Sales Channels, Direct Sales and Distribution
Figure 23. Tablet
Figure 24. Capsules
Figure 25. Other
Figure 26. By Type, Global Solid Preparation Drug Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Solid Preparation Drug Revenue Market Share, 2018-2029
Figure 28. By Type, Global Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Solid Preparation Drug Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Solid Preparation Drug Price, 2018-2029, (US$/Unit)
Figure 31. Hospital
Figure 32. Retail Pharmacy
Figure 33. Other
Figure 34. By Application, Global Solid Preparation Drug Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Solid Preparation Drug Revenue Market Share, 2018-2029
Figure 36. By Application, Global Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Solid Preparation Drug Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Solid Preparation Drug Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Solid Preparation Drug Revenue Market Share, 2018-2029
Figure 40. By Region, Global Solid Preparation Drug Sales Volume Market Share, 2018-2029
Figure 41. North America Solid Preparation Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Solid Preparation Drug Revenue Market Share, 2022
Figure 43. Europe Solid Preparation Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Solid Preparation Drug Revenue Market Share, 2022
Figure 45. Asia Pacific Solid Preparation Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Solid Preparation Drug Revenue Market Share, 2022
Figure 47. South America Solid Preparation Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Solid Preparation Drug Revenue Market Share, 2022
Figure 49. Middle East & Africa Solid Preparation Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Solid Preparation Drug Market Share, 2022
Figure 52. By Type, U.S. Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Solid Preparation Drug Market Share, 2022
Figure 56. By Type, Europe Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 58. China Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Solid Preparation Drug Market Share, 2022
Figure 60. By Type, China Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Solid Preparation Drug Market Share, 2022
Figure 64. By Type, Japan Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Solid Preparation Drug Market Share, 2022
Figure 68. By Type, South Korea Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Solid Preparation Drug Market Share, 2022
Figure 72. By Type, Southeast Asia Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 74. India Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Solid Preparation Drug Market Share, 2022
Figure 76. By Type, India Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Solid Preparation Drug Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Solid Preparation Drug Market Share, 2022
Figure 80. By Type, Middle East & Asia Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Solid Preparation Drug Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|